Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sebag-Montefiore

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 1, 2025
Radiating Excellence: A Decade of Pioneering Radiotherapy Trials and Collaborative Leadership at Leeds Cancer Research UK Clinical Trials UnitF Slevin, E M Hudson, A Hockaday, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 4, 2016
Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health ServiceE J A Morris, P J Finan, K Spencer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 2, 2023
Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled TrialsE M Hudson, F Slevin, K Biscombe, et al.
The British Journal of Radiology|December 23, 2011
An evaluation of four CT-MRI co-registration techniques for radiotherapy treatment planning of prone rectal cancer patientsC J Dean, J R Sykes, R A Cooper, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 24, 2021
Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After ChemoradiotherapyK Wakeham, L Murray, R Muirhead, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trialR Glynne-Jones, L Kadalayil, H M Meadows, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 9, 2016
Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal CarcinomaG Ward, S Ramasamy, J R Sykes, et al.
Pilot and Feasibility Studies|December 15, 2016
The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Pilot and Feasibility Studies|December 16, 2016
Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 26, 2013
The English national low rectal cancer development programme: key messages and future perspectivesB J Moran, T Holm, G Brannagan, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 1, 2025
Radiating Excellence: A Decade of Pioneering Radiotherapy Trials and Collaborative Leadership at Leeds Cancer Research UK Clinical Trials UnitF Slevin, E M Hudson, A Hockaday, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 4, 2016
Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health ServiceE J A Morris, P J Finan, K Spencer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 2, 2023
Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled TrialsE M Hudson, F Slevin, K Biscombe, et al.
The British Journal of Radiology|December 23, 2011
An evaluation of four CT-MRI co-registration techniques for radiotherapy treatment planning of prone rectal cancer patientsC J Dean, J R Sykes, R A Cooper, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 24, 2021
Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After ChemoradiotherapyK Wakeham, L Murray, R Muirhead, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trialR Glynne-Jones, L Kadalayil, H M Meadows, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 9, 2016
Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal CarcinomaG Ward, S Ramasamy, J R Sykes, et al.
Pilot and Feasibility Studies|December 15, 2016
The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Pilot and Feasibility Studies|December 16, 2016
Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 26, 2013
The English national low rectal cancer development programme: key messages and future perspectivesB J Moran, T Holm, G Brannagan, et al.
Pageof 6